A traditional ginseng-family root with a two-way effect on blood, slowing bleeding while improving flow. Its most consistent action is reducing blood-cell stickiness and supporting circulation, with add-on signals after stroke and heart attack. Evidence is weak and mostly from ill patients; generally well-tolerated, but blood-thinner effects are unpredictable and it should be avoided in pregnancy. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Platelet count | ~150–400 ×10⁹/L | Baseline clotting capacity; screens for low platelets |
| INR | ~0.8–1.1 (off anticoagulants) | Detects excessive blood thinning |
| hs-CRP | < 1.0 mg/L | Tracks systemic inflammation |
| LDL cholesterol | < 100 mg/dL | Follows the lipid angle of cardiovascular benefit |
| Fasting glucose / HbA1c | ~70–90 mg/dL / < 5.4% | Monitors the metabolic effect and additive risk with diabetes drugs |
| eGFR | > 90 mL/min/1.73m² | Baseline and ongoing kidney function |
| ALT / AST | ~10–30 U/L | Liver function, since the saponins are liver-metabolized |
Cadence: Baseline before starting, a follow-up at about 4–8 weeks, then every 6–12 months during continued use; recheck clotting tests whenever the dose changes or an interacting drug is added.